N@N

Market Maker Surveillance Report. NUS, MSON, RIMM, AMPL, ALXA, RPTP, Losing Stocks With Lowest Price Friction For Friday, Dece

^{Published on 2012-12-21 18:00:28 - WOPRAI}
 

December 21, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 4158 companies with "abnormal" market making, 2002 companies with positive Friction Factors and 3683 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Friday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. NU Skin Enterprises Inc (NYSE:NUS), Misonix Inc (NASDAQ:MSON), RESEARCH IN MOTION (NASDAQ:RIMM), Ampal-American Israel Corp (NASDAQ:AMPL), Alexza Pharmaceuticals Inc (NASDAQ:ALXA), Raptor Pharmaceutical Corp (NASDAQ:RPTP). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  NUS     $-5.400   -13.52%   2,025,221    29.24%    2,051,393    29.62%    -26,172      -48     
  MSON    $-1.110   -14.60%   125,185      44.91%    150,654      54.05%    -25,469      -229    
  RIMM    $-3.360   -23.80%   72,952,099   49.03%    75,479,912   50.73%    -2,527,813   -7,523  
  AMPL    $-0.580   -16.11%   142,069      45.20%    171,634      54.61%    -29,565      -510    
  ALXA    $-1.270   -20.42%   1,159,401    47.19%    1,193,822    48.59%    -34,421      -271    
  RPTP    $-0.880   -14.92%   247,391      32.20%    467,853      60.90%    -220,462     -2,505  

For example, the chart above shows NUS with a dollar loss Friday of $-5.40000 and a Friction Factor of -48 shares. That means that it only took 48 more shares of selling than buying to move NUS lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

NU Skin Enterprises Inc (NYSE:NUS) - Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements worldwide. The company sells its personal care products under the Nu Skin brand; and nutritional supplements under the Pharmanex brand. Its personal care product line includes core systems, such as ageLOC Transformation skin care system, Nu Skin 180 anti-aging skin therapy system, Nu Skin tri-phasic white, nutricentials, and Nu Skin Clear Action acne medication system; targeted treatments, including galvanic spa system, spa gels, spa body shaping gel, dermatic effects body contouring lotion, line corrector, skin conditioning gel, ultra recovery fluid, moisturizer, and skin refinisher; and total care line of products, such as body bar, liquid body lufra, body moisturizer, men s and dental care products, and hair mask. The company s personal care products also comprise Nu Colour line of cosmetic products, including tinted moisturizer, finishing powder, lip gloss, and mascara; and Epoch product line, such as body butter, foot treatment product, skin cream, marine mud, leg gel, shave gel, shampoo, and baby hair and body wash products. The company s nutritional supplements product line comprises micronutrient supplements, anti-aging products, and solutions supplements, as well as weight management products, including supplements and meal replacement shakes. It also sells Vitameal, a nutritious meal product to feed malnourished children or for personal food storage; and household products and digital content storage. The company sells its products primarily through a network of independent distributors in north Asia, the Americas, Greater China, Europe, and the south Asia/Pacific; and through its retail stores in China. As of December 31, 2011, it operated 40 stores in China. The company was founded in 1984 and is headquartered in Provo, Utah..

Misonix Inc (NASDAQ:MSON) - Misonix, Inc. designs, manufactures, develops, and markets minimally invasive ultrasonic medical device products. The company offers BoneScalpel cutting system, which is used for surgical procedures of the spine and on maxillofacial procedures; SonaStar surgical aspirator that is used to emulsify and remove soft and hard tumors; and SonicOne wound cleansing and debridement system for the removal of devitalized tissue and fibrin deposits while sparing viable cells. It also markets the AutoSonix ultrasound cutting and coagulating system; and Lysonix ultrasound assisted liposuction device. In addition, it provides HiSonic ultrasonic technology for the treatment of profound deafness and tinnitus. The company sells its products through independent sales agents, direct sales persons, and distributors. It has operations in the United States, Australia, Europe, Asia, Canada, Mexico, South America, South Africa, and the Middle East. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York..

RESEARCH IN MOTION (NASDAQ:RIMM) - Research In Motion Limited (RIM) designs, manufactures, and markets wireless solutions for the worldwide mobile communications market. The company, through the development of integrated hardware, software, and services, provides platforms and solutions for seamless access to time-sensitive information, including email, phone, short messaging service, and Internet and Intranet-based applications and browsing. Its products and services principally comprise the BlackBerry wireless platform, the RIM Wireless Handheld product line, software development tools, and other software and hardware. The companys BlackBerry smartphones use wireless, push-based technology that delivers data to mobile users business and consumer applications. Its BlackBerry smartphone portfolio includes BlackBerry Bold series, the BlackBerry Torch, BlackBerry Curve series, the BlackBerry Style, BlackBerry Storm series, the BlackBerry Tour, BlackBerry Pearl series, and the BlackBerry PlayBook tablet. The companys BlackBerry enterprise solutions comprise BlackBerry enterprise server, BlackBerry enterprise server express, BlackBerry mobile voice system, and hosted BlackBerry services. Its technology also enables third party developers and manufacturers to enhance their products and services through software development kits, wireless connectivity to data, and third-party support programs. In addition, the company offers BlackBerry technical support services, non-warranty repairs, and nonrecurring engineering services. Further, it provides BlackBerry App World that offers BlackBerry smartphone users an electronic catalogue that aids in the discovery and download/purchase of applications directly from their BlackBerry smartphone. The company markets and sells its BlackBerry wireless solutions primarily through global wireless communications carriers, and third party distribution channels. Research In Motion Limited was founded in 1984 and is headquartered in Waterloo, Canada..

Ampal-American Israel Corp (NASDAQ:AMPL) - Ampal-American Israel Corporation acquires interests in businesses located in the State of Israel or that are Israel-related. It invests in companies in energy, real estate and project development, and leisure. The company provides its investee companies with ongoing support through its involvement in the investees strategic decisions and introduction to the financial community, investment bankers, and other potential investors both in and outside of Israel. Ampal is a New York corporation founded in 1942 and is headquartered in New York, New York..

Alexza Pharmaceuticals Inc (NASDAQ:ALXA) - Alexza Pharmaceuticals, Inc., a development stage company, focuses on the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are based on a proprietary technology, the Staccato system that vaporizes an excipient-free drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. The companys clinical-stage product candidates comprise AZ-004 (staccato loxapine), which is licensed to Biovail Laboratories International SRL for the acute treatment of agitation in patients with schizophrenia or bipolar disorder; AZ-007 (staccato zaleplon), which completed phase I status for the treatment of insomnia; and AZ-001 (staccato prochlorperazine) and AZ-104 (staccato loxapine, low-dose), phase II product candidates for the treatment of migraine headache. It also develops AZ-002 (Staccato alprazolam), which completed a phase 1 clinical trial in healthy subjects and a phase 2a proof-of-concept clinical trial in panic disorder patients for the treatment of panic attacks; and AZ-003 (Staccato fentanyl) that completed phase 1 clinical trial for the treatment of patients with acute pain, including patients with breakthrough cancer pain and postoperative patients with acute pain episodes. The company was formerly known as Alexza Molecular Delivery Corporation and changed its name to Alexza Pharmaceuticals, Inc. in July 2005. Alexza Pharmaceuticals, Inc. was founded in 2000 and is based in Mountain View, California..

Raptor Pharmaceutical Corp (NASDAQ:RPTP) - Raptor Pharmaceuticals Corp. operates as a development stage biotechnology company in the United States. The company engages in the discovery, research, and preclinical development of drug candidates and drug-targeting platforms for the treatment of various brain disorders and neurodegenerative diseases, genetic disorders, and cancer through the proprietary use of receptor-associated proteins and mesoderm development proteins. Its clinical-stage products include DR Cysteamine, which is in Phase IIb clinical trail for the treatment of nephropathic cystinosis or cystinosis; and in Phase IIa clinical trail for the treatment of non-alcoholic steatohepatitis. The company also develops Convivia, a Phase IIa clinical trail product for the treatment of aldehyde dehydrogenase or ALDH2 deficiency; DR Cysteamine, which is in Phase II clinical trail for the treatment of Huntingtons Disease; and Tezampanel and NGX 426 that is in Phase II clinical trail for the treatment of migraine, acute pain, and chronic pain. In addition, its preclinical development products comprise HepTide for the treatment of Hepatocellular Carcinoma and Hepatitis C; WntTide for the treatment of breast cancer; and NeuroTrans for the treatment of neurodegenerative diseases. The company has collaboration agreements with the University of California, San Diego for a clinical study of DR Cysteamine in juvenile patients with Non-Alcoholic Steatohepatitis and to study DR Cysteamine in patients with cystinosis. Raptor Pharmaceuticals Corp was founded in 2005 and is based in Novato, California..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net